Form 8-K - Current report:
SEC Accession No. 0001493152-24-017488
Filing Date
2024-05-02
Accepted
2024-05-02 08:00:18
Documents
18
Period of Report
2024-04-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 76935
2 ex3-1.htm EX-3.1 150007
3 ex99-1.htm EX-99.1 25930
4 ex3-1_001.jpg GRAPHIC 97828
5 ex3-1_002.jpg GRAPHIC 62802
6 ex3-1_003.jpg GRAPHIC 72440
  Complete submission text file 0001493152-24-017488.txt   793592

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20240429.xsd EX-101.SCH 3033
8 XBRL LABEL FILE mgrx-20240429_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE mgrx-20240429_pre.xml EX-101.PRE 22371
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3925
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 24905389
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)